Last --
Change Today 0.00 / 0.00%
Volume 0.0
RLS/P On Other Exchanges
All times are local (Market data is delayed by at least 15 minutes).

royal lifescience corp (RLS/P) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ROYAL LIFESCIENCE CORP (RLS/P)

Related News

No related news articles were found.

royal lifescience corp (RLS/P) Related Businessweek News

No Related Businessweek News Found

royal lifescience corp (RLS/P) Details

Royal Lifescience Corp. was founded in 2011 and is headquartered in Vancouver, Canada.

Founded in 2011

royal lifescience corp (RLS/P) Top Compensated Officers

Chief Executive Officer, Chief Financial Offi...
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

royal lifescience corp (RLS/P) Key Developments

Royal Lifescience To Transfer Its Listing From Tier 2 To NEX

In accordance with TSX Venture Policy 2.4, Capital Pool Companies, the Royal Lifescience Corp. has not completed a Qualifying Transaction within the prescribed time frame. Therefore, effective at the opening on July 30, 2014, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Vancouver to NEX.

Royal Lifescience’s Shares Suspended From TSX Venture Exchange

Further to the TSX Venture Exchange Bulletin dated March 31, 2014, effective at the open May 1, 2014 trading in the shares of the Royal Lifescience Corp. will be suspended, the Company having failed to complete a Qualifying Transaction within 24 months of its listing.

Royal Lifescience Corp., Annual General Meeting, Jul 09, 2014

Royal Lifescience Corp., Annual General Meeting, Jul 09, 2014., at 10:00 Pacific Standard Time. Location: 1780 ­ 400 Burrard Street. Agenda: To consider the audited financial statements for the year ended September 30, 2013; to appoint MNP LLP as auditors and to authorize the directors to fix the remuneration; to set the number of directors of the Company for the ensuring year at three persons; to elect the directors; to consider, and if thought appropriate, to ratify and approve the existing 10% rolling Option Plan; to consider, and if thought appropriate, to approve the cancellation of certain "seed shares" of Company; to consider, and if thought appropriate, to approve the transfer of the common shares of the Company to the NEX trading board of the TSXV in the event the Proposed Qualifying Transaction is not completed by July 29, 2014 (or such later delisting date as may be approved by the TSXV), as more fully described in the Circular; and to transact such other business as may properly come before the Meeting and any adjournment thereof.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RLS/P:CN C$0.00 CAD 0.00

RLS/P Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RLS/P.
View Industry Companies

Industry Analysis


Industry Average

Valuation RLS/P Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 0.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROYAL LIFESCIENCE CORP, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at